← Open Payments lookup

KAITLYN GOVATOS: Open Payments

NPI 1780237966 · ARNOLD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$652 in 25 payments from 10 companies in 2025. Trend: 2023 $347 · 2024 $215 · 2025 $652

Food & beverage: $652
CompanyPaymentsAmount
ABBVIE INC.8$179
Novo Nordisk Inc7$167
Medtronic, Inc.1$104
Astellas Pharma US Inc2$48
Boston Scientific Corporation1$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$36
Optinose US, Inc.1$21
Amgen Inc.1$20
Otsuka America Pharmaceutical, Inc.1$17
Collegium Pharmaceutical, Inc.1$14

Products named: VRAYLAR, SYMPLICITY G3, Ozempic, Rybelsus, Veozah, WaveWriter Alpha Prime 16, XIFAXAN, Wegovy.

Industry payments across MD — which companies pay providers there.